It is great to see that the UK Department of Health (DH) and the Chinese Ministry of Science and Technology (MoST) have today announced the size, scope and eligibility for the UK-China AMR Collaboration that was initially announced in 2016. DH will to invest up to £10 million in UK businesses and MoSt will provide to 60 million RMB to fund the Chinese partners. The competition will open at the start of 2018 -- more precise dates will be announced in due course.
The aim is to support novel products or services against antimicrobial resistance (AMR) that neither country would be able to conduct within the same timeframe without the other’s expertise. Where appropriate, clinical evaluation can be supported. Specifically, the call will seek projects that:
Well done to all for working to make this happen!
All best wishes, --jr
John H. Rex, MD | Chief Medical Officer, F2G Ltd. | Chief Strategy Officer, CARB-X | Expert-in-Residence, Wellcome Trust. Follow me on Twitter: @JohnRex_NewAbx. See past newsletters and subscribe for the future: http://amr.solutions/blog.html
Upcoming meetings of interest to the AMR community: